Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Protein tyrosine kinase inhibitors from Warner-Lambert

Dec. 31, 1996

Beiersdorf-Lilly claims angiotensin II blockers

Dec. 30, 1996

Hyal products for restenosis receive U.S. patent coverage

Dec. 24, 1996

Intercardia and Knoll reach agreement for CHF drug

Dec. 24, 1996

Genzyme commences cardiovascular gene therapy collaboration

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Biovail grants another license for diltiazem product

Dec. 18, 1996

Beta-blocker treatment reduces fatal post-surgical heart attack

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...